Fatigue Assessment Included in Simponi Aria Labeling
The prescribing information for the product has been updated to include this health related outcome.
Rheumatoid Arthritis
Managing RA: Consider Potential Interactions With JAK Inhibitors
Given that treatment options for RA are rapidly changing, the study authors aimed to summarize information surrounding potential drug-drug interactions with JAK inhibitors in order to help health care providers make informed decisions.
WellDyne to Provide Physician Access to Scipher Medicine’s PrismRA Blood Test
WellDyne will provide physicians access to Scipher Medicine’s PrismRA test, which identifies RA patients unlikely to respond to TNFi therapy.
Tofacitinib vs TNFi for RA: Safety Study Results Announced
The randomized phase 3b/4 ORAL Surveillance study included 4362 RA patients who were taking methotrexate without adequate control of symptoms.
FDA to Review AVT02, a High Concentration Biosimilar to Adalimumab
AVT02 is a proposed biosimilar to Humira® (adalimumab) with high concentration (100mg/mL) dosage forms.
RediTrex Now Available for RA, pJIA, Psoriasis Treatment
RediTrex is approved for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, and psoriasis.
Study Supports Switching Between Upadacitinib and Adalimumab in RA
Researchers evaluated the safety and efficacy of switching between upadacitinib and adalimumab in patients with rheumatoid arthritis with nonresponse or incomplete response to initial therapy.
Glucocorticoids Linked to Hospitalized Infection Risk in RA
Risk for hospitalized infections up for patients with RA receiving DMARDs with continued glucocorticoid use
Curcuma longa Extract Improves Knee Pain in Osteoarthritis
CL improved pain but did not change effusion-synovitis volume or cartilage composition.
Early Therapy for Rheumatoid Arthritis May Slow Heart Disease
RA treatment response does not appear to impact improvement in vascular stiffness.
